Why not? [Power / Sample Size]

posted by jag009  – NJ, 2013-05-09 22:12 (4787 d 05:26 ago) – Posting: # 10563
Views: 8,588

Hi Helmut,

❝ Essentially yes. You have to get the degrees of freedom right. See Detlew’s post.


Question (obvious answer I am sure). The degrees of freedom for a 3-period 3-sequence 2-treatment partial replicate should be similar to that of a 3-period 3-sequence 3-treatment crossover right?

❝ P.S.: Any news from Donald Schuirmann? ;-)


Waiting...

Thx
John

Complete thread:

UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,571 registered users;
170 visitors (0 registered, 170 guests [including 17 identified bots]).
Forum time: 03:38 CEST (Europe/Vienna)

“Data! Data! Data!” he cried impatiently.
“I can’t make bricks without clay!”    Arthur Conan Doyle

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5